Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Wagner

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
The Lancet. Oncology|February 12, 2011
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyJack Cuzick, Gregory P Swanson, Gabrielle Fisher, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
JCO Precision Oncology|November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry CompositionElisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2024
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factorsBrent Mabey, Elisha Hughes, Matthew Kucera, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
The Lancet. Oncology|February 12, 2011
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyJack Cuzick, Gregory P Swanson, Gabrielle Fisher, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
JCO Precision Oncology|November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry CompositionElisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2024
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factorsBrent Mabey, Elisha Hughes, Matthew Kucera, et al.
Pageof 8